AzurRx BioPharma now has five additional shots on goal “with the imminent full acquisition of just one compound,” a ROTH Capital Partners report noted. In a Sept. 17 research note, analyst Jonathan …
More Target Price Raised On Biopharma After It Acquires Company, Splits Stock Videos